Faye Cooles Consultant Rheumatologist Newcastle

Faye Cooles Consultant Rheumatologist Newcastle: Expertise and Commitment

Faye Cooles Consultant Rheumatologist Newcastle brings exceptional medical knowledge and extensive clinical experience to patients throughout the North East of England. Dr. Cooles began her medical journey at the University of Edinburgh, earning her MBChB degree with Honours in 2009. Since then, she has worked tirelessly in Newcastle and surrounding areas, developing expertise in Rheumatology and connecting deeply with her community.

Comprehensive Training and International Experience

Dr. Faye Cooles Consultant Rheumatologist Newcastle gained invaluable clinical skills through a combined clinical and postdoctoral research fellowship. From 2022 to 2023, she trained at Arthritis Research Canada (ARC) and the University of British Columbia in Vancouver. During this time, she worked at the Mary Pack Arthritis Centre and Vancouver General Hospital. This experience allowed her to manage a wide range of common and rare rheumatic conditions with confidence and precision.

Qualifications and Specialist Interests

Her impressive qualifications include MBChB (Hons), BSc (Hons), MRes, PhD, and MRCP. Notably, Dr. Cooles specializes in managing Connective Tissue Diseases. These include Sjogren’s Disease, systemic lupus erythematosus, and systemic sclerosis. Because of her dedication, patients receive expert care tailored to these complex conditions.

Research Leadership by Faye Cooles Consultant Rheumatologist Newcastle

Moreover, Dr. Cooles earned her PhD from Newcastle University in 2017. She currently leads a research group focused on type 1 interferons and their role in rheumatic diseases. Additionally, she plays a key role in the Newcastle NIHR Biomedical Research Centre. As Co-lead of the Connective Tissue Disease workstream in the UK NIHR/Versus Arthritis Musculoskeletal Translational Research Collaboration (UK MSK TRC), she drives innovative research forward. Thus, her clinical practice continually benefits from cutting-edge discoveries.